Alteogen Inc.
196170
Rangering i aksjer
#1916
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters,... ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial; and Biogen Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Aksjekurs
$159.04
Markedsverdi
$11.07B
Endring (1 dag)
-2.95%
Endring (1 år)
-48.94%
Land
KR
Handel Alteogen Inc. (196170)
Kategori
Healthcare
Utbyttehistorikk for Alteogen Inc. (196170)
Alteogen Inc. (aksjesymbol: 196170) har gitt totalt 1 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $371.00
Utbytteavkastning (TTM): 0.0018
Summen av alle utbytter (justert for aksjesplitt): $371.00
Utbytteavkastning (TTM): 0.0018
Utbyttebetalinger for Alteogen Inc. (196170) fra 2025 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $371.00 | 0.00% |
| 2025 | $371.00 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $371.00 | 0.00% |
| 2025 | $371.00 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
